Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.
Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death, highlighting an urgent need for cardiovascular screening in these patients.
"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.
A recent study found that patients taking NSAIDs concurrently with oral anticoagulants had more than twice the bleeding risk compared with patients only taking anticoagulants.